| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers P > Headlines for PPD, Inc. > News item |
Pharmaceutical Product Development to redeem some 6 3/8% notes
Chicago, May 21 – PPD, Inc. announced that it plans to use proceeds from a new bond issue to redeem a portion of its 6 3/8% senior notes due 2023 issued by Pharmaceutical Product Development, LLC, an indirect wholly owned subsidiary of Jaguar Holding Co. II, according to a press release.
The $1,125,000,000 offering of notes was originally issued in August 2015.
The company is planning an offering of $700 million of new notes, announced Thursday.
Wilmington, N.C.-based Pharmaceutical Product Development provides clinical trial and laboratory services to the pharmaceutical and biotechnology industries.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.